Search
Searching Content indexed under Privacy Protection by Teresa Reguly ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
New Rule Clarifies Circumstances Requiring Breach Reporting Under Ontario PHIPA
The Ontario government recently amended the Personal Health Information Protection Act (PHIPA) to include mandatory breach reporting.
Canada
27 Jul 2017
2
Trump Executive Order Minimizes U.S. Privacy Act Protections For Non-U.S. Citizens
U.S. President Trump's recent executive orders have received significant attention.
Canada
15 Feb 2017
3
Canada's Privacy Commissioner Enters The CASL Enforcement Ring
The Office of the Privacy Commissioner of Canada (OPC) has concluded its first investigation under the "address-harvesting" provisions added to PIPEDA by the enactment of Canada's anti-spam legislation.
Canada
6 Jun 2016
4
Privacy Obligations For Organizations And Employee Snooping
The issue of "employee snooping" is currently top of mind with the Office of the Privacy Commissioner of Canada (the OPC).
Canada
27 Apr 2016
5
Court Of Appeal Affirms: Privacy Tort Applies To Breach Of Private Health Information
In a decision of particular significance to healthcare institutions and their employees, the Ontario Court of Appeal has affirmed the applicability of the common law tort of intrusion upon seclusion in the healthcare context.
Canada
26 Feb 2015
6
Privacy Tort Applies To Breach Of Private Health Information
The Ontario Superior Court of Justice has considered the applicability of the common law tort of intrusion upon seclusion in the context of healthcare.
Canada
11 Oct 2014
7
Look Before You Leap: Pre-Canadian Launch Regulatory Considerations For U.S. Companies
Deciding whether or not to launch a food, drug, medical device, dietary supplement or cosmetic product in Canada involves a number of considerations.
Canada
20 May 2014
8
Proposed Privacy Reforms Made Public
On April 8, 2014, the Canadian Government introduced the Digital Privacy Act in the Senate.
Canada
16 Apr 2014
9
Biosimilars In Canada: New Draft Guidelines From Health Canada
Health Canada announced that it had granted marketing authorization for Omnitrope (a human growth hormone), the first subsequent entry biologic (SEB) to be approved for sale in Canada.
Canada
22 Jul 2009
10
Canada´s Regulation Of Subsequent Entry Biologics
Health Canada has released a revised version of the draft guidance document "Information and Submission Requirements for Subsequent Entry Biologics".
Canada
8 Apr 2009
Links to Result pages
 
1